EZH2 and colorectal cancer: Analysis of larger colorectal cancer datasets further revealed consistent upregulation of EZH2, EED, and UHRF1 in BRAF-mutant CRCs compared to BRAF-wildtype tumors, reinforcing the broader relevance of these findings.